Replies to post #10526 on StocksDiva Bio Bin

[PoemStone]

ARIA. ARIAD Announces Publication of Ponatinib Phase 1 Clinical Trial Results in the New England Journal of Medicine

Results demonstrate that ponatinib is highly active in heavily pretreated patients with CML and Ph + ALL
http://phx.corporate-ir.net/phoenix.zhtml?c=118422&p=irol-newsArticle&ID=1762703&highlight=